MIPS Home MIPS General Information MIPS Grants MIPS Courses MIPS Research MIPS Software MIPS Web Tools MIPS Sitemap
About MIPS MIPS News Faculty & Staff Recent Pubs Directions Facilities Events & Meetings Employment Associated Depts Useful Links
Grant News CCNE-TR CVIS ICMIC ICBP NTROI SMIS
BIOE222 Pharmacokinetics Stats & Data Analysis
BIOE222A F2009 BIOE222B W2009 BIOE222A F2008 BIOE222B W2008 BIOE222A F2007 BIOE222B W2007 BIOE222 F2006 BIOE222 F2005 BIOE222 F2004
Biswal Lab Blankenberg Lab Cheng Lab Contag Lab Felsher Lab Gambhir Lab Graves Lab Guccione Lab Levin Lab Lin Lab McConnell Moseley Lab Paik Lab Plevritis Lab Ramasamy Lab Rao Lab Rutt Lab Schnitzer Lab Vasanawala Lab Willmann Lab Wu Lab Xing Lab
NCIL MRSRL
AMIDE
NucMed Mediabook PET Brain Atlas PET-FDG Whole Body Atlas




CCNE Home

Nanobiotechnology Seminar

Annual Symposium

CCNE News

Faculty

Postdocs
Graduate Students

Scientific Papers

Corporate Collaboration

Private Foundations

Projects

Core Resources

Pilot Projects

Leadership & Organization

Environment


Center for Cancer Nanotechnology Excellence Focused on Therapy Response

Environment


Crump Institute for Molecular Imaging (UCLA) Environment

The Crump Institute for Molecular Imaging (CIMI) is an Organizational Research Unit (ORU) of the UCLA School of Medicine. CIMI was founded in 1989 as a multidisciplinary research Institute dedicated to the development and use of imaging technology to study molecular systems. The Institute is currently directed by Dr. Michael E. Phelps, and is co-directed by Dr. Anna Wu (CCNE-TR Project Leader 6) and was previously directed by Dr. Gambhir (CCNE-TR PI) before he moved from UCLA to Stanford.

The Institute has five key research areas focusing on: synthesis of radiolabeled and fluorescent probes for molecular imaging; development of in-vivo molecular imaging systems based on high-resolution positron emission tomography (PET); development of molecular imaging approaches for interrogating cellular events in living subjects; the use of PET imaging and in-situ hybridization to study brain development and plasticity in the rat; and development of imaging/therapeutic probes for cancer diagnosis/management. Other areas of active interest to the Institute are: 3-D image reconstruction in PET and CEM; studies of the cost-effectiveness of clinical nuclear medicine procedures; development of quantitative molecular imaging assays; the application of imaging technologies for high throughput phenotypic screening; the development of novel software tools and applications to support research and education connected to the mission of the Institute.

Funding for the Institute's research activities comes from a mix of Federal, Foundation and University sources, as well as through a number of collaborations with Industry. The Institute runs several state-of-the-art imaging facilities within its laboratories including confocal microscopy (Leica CLSM), digital autoradiography (Fuji BAS 5000), optical CCD (Xenogen) camera, microCT (Imtek) and two high resolution animal PET scanners (microPET).

[ Back ]
crumpnews events